Pennsylvania’s growing medical marijuana industry received two major green lights Monday morning.
Following recommendations highlighted last month, the Department of Health officially added opioid addiction to the list of approved conditions that can be treated by medicinal cannabis. And in a major boon to Philadelphia, five local institutions were awarded research licenses to study cannabis.
“It’s important to note that medical marijuana is not a substitute for proven treatments for opioid-use disorder,” Secretary of Health Dr. Rachel Levine said. “In Pennsylvania, medical marijuana will be available to patients if all other treatment fails, or if a physician recommends that it be used in conjunction with traditional therapies.”
Pennsylvania is the only state to allow the treatment of opioid-use disorder with medicinal marijuana.
Philadelaphia, in particular, continues to battle a burgeoning epidemic after 1,200 people died in 2017 of drug overdoses. Several